DENTSPLY SIRONA


Associated tags: Dental care, Patient, Health, Sirona, XRAY, Dentsply Sirona

Locations: CHINA, AUSTRIA, CANADA, NORTH AMERICA, LOUISIANA, NEW YORK, CALIFORNIA, CHARLOTTE, NC, US, GOLDMAN, UNITED STATES

Dentsply Sirona to Participate in Upcoming Investor Conferences

Retrieved on: 
Thursday, May 30, 2024

CHARLOTTE, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.

Key Points: 
  • CHARLOTTE, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
  • William Blair 44th Annual Growth Stock Conference on June 5, 2024, at 9:20 am CT (10:20 am ET)
    Goldman Sachs 45th Annual Global Healthcare Conference on June 13, 2024, at 8:00 am ET

Dentsply Sirona Declares Quarterly Cash Dividend

Retrieved on: 
Wednesday, May 22, 2024

CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.

Key Points: 
  • CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.
  • The dividend is payable on July 12, 2024, to holders of record as of June 28, 2024.

DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY

Retrieved on: 
Friday, May 10, 2024

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Dentsply Sirona, Inc. (NasdaqGS: XRAY).

Key Points: 
  • Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Dentsply Sirona, Inc. (NasdaqGS: XRAY).
  • The Company has been sued in securities class action lawsuits for failing to disclose material information, violating federal securities laws, which remain pending.
  • Recently, the court presiding over that case denied the Company’s motion to dismiss in part, allowing the case to move forward.
  • KSF’s investigation is focusing on whether Dentsply’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.

Dentsply Sirona to Participate in Upcoming Investor Conferences

Retrieved on: 
Wednesday, May 8, 2024

CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.

Key Points: 
  • CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
  • Bank of America 2024 Health Care Conference on May 15, 2024, at 9:20 am PT (12:20 pm ET)
    Stifel 2024 Jaws and Paws Conference on May 29, 2024, at 12:40 pm ET
    Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.

Dentsply Sirona to Host First Quarter Conference Call on May 2nd

Retrieved on: 
Tuesday, April 9, 2024

CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 2, 2024, at 8:30 am ET to review its first quarter financial results.

Key Points: 
  • CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 2, 2024, at 8:30 am ET to review its first quarter financial results.
  • A presentation related to the call will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com.
  • A live webcast will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com.
  • A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors

Retrieved on: 
Thursday, February 29, 2024

CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company’s Board of Directors (the “Board”) for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election.

Key Points: 
  • CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company’s Board of Directors (the “Board”) for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election.
  • Mr. Brandt commented, “As I think back on the past two decades and all of the challenges we’ve navigated together, I am grateful for the talented and dedicated individuals with whom I have had the privilege to serve.
  • I am proud of the strong and diverse Board that we have assembled and I believe it's the right time for me to step aside.
  • His unwavering support and guidance, and insightful contributions have been instrumental in shaping the Company’s future.

Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend

Retrieved on: 
Thursday, February 29, 2024

Full year 2023 net sales of $3,965 million increased 1.1% (organic sales increased 2.2%), compared to the full year of 2022.

Key Points: 
  • Full year 2023 net sales of $3,965 million increased 1.1% (organic sales increased 2.2%), compared to the full year of 2022.
  • Fourth quarter net sales of $1,012 million increased 2.9% (organic sales increased 1.9%) compared to the fourth quarter of 2022.
  • Net income was $67 million, or $0.32 per diluted share, compared to net income (loss) of ($15) million, or ($0.07) per share in the fourth quarter of 2022.
  • Adjusted earnings per diluted share were $0.44 compared to $0.46 in the fourth quarter of 2022.

Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th

Retrieved on: 
Monday, January 29, 2024

CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results.

Key Points: 
  • CHARLOTTE, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 29, 2024, at 8:30 am ET to review its fourth quarter and full year 2023 financial results.
  • A presentation related to the call will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com .
  • A live webcast will be available on the Investors section of the Company’s website at https://investor.dentsplysirona.com .
  • A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.

Dentsply Sirona announces that DS World Las Vegas 2024 will take place on September 26-28 at Caesars Forum

Retrieved on: 
Thursday, January 18, 2024

CHARLOTTE, N.C., Jan. 18, 2024 /PRNewswire/ -- Dentsply Sirona today announced that its 2024 DS World Las Vegas event will take place on September 26-28 at Caesars Forum.

Key Points: 
  • CHARLOTTE, N.C., Jan. 18, 2024 /PRNewswire/ -- Dentsply Sirona today announced that its 2024 DS World Las Vegas event will take place on September 26-28 at Caesars Forum.
  • While the event was previously scheduled to take place in early October, the date was changed in response to customer feedback.
  • Dentsply Sirona World in Las Vegas is one of the dental industry's most anticipated annual clinical education events.
  • More details about the program for Dentsply Sirona World 2024 will be announced soon.

Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results

Retrieved on: 
Tuesday, January 9, 2024

CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).

Key Points: 
  • CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 7:30 am PT (10:30 am ET).
  • As part of the conference, the Company is providing an update on its 2023 full year anticipated financial results, with net sales expected to be at or above the high end of the Company’s previously provided outlook range of $3.90 billion to $3.94 billion.
  • The Company is reaffirming its full year 2023 adjusted EPS outlook range of $1.80 to $1.85 and its expectations for double-digit adjusted EPS growth in 2024.
  • The preliminary estimates above are based solely upon information available to management as of the date of this press release and are subject to change.